Array cancer drug gets FDA's breakthrough therapy designation

Array cancer drug gets FDA's breakthrough therapy designation


Boulder-based pharmaceutical firm Array BioPharma Inc. has received the U.S. Food and Drug Administration's breakthrough therapy designation for an investigational drug combination to treat colorectal cancer, according to a company news release.



from Biotech News